Sriram Rampalli

Title: Sriram Rampalli: Innovator in Pharmaceutical Chemistry

Introduction

Sriram Rampalli is a notable inventor based in Vizianagaram, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for cancer treatment. With a total of four patents to his name, Rampalli's work is recognized for its potential impact on medical therapies.

Latest Patents

Among his latest patents is the invention of polymorphs of Ribociclib mono succinate. This invention relates to novel crystalline and amorphous polymorphic forms of Ribociclib mono succinate, which may be useful in the improved preparation of oral dosage forms for the treatment of cancer. Another significant patent involves a process for the preparation of Ibrutinib, a compound known for its application in cancer therapy. This invention details a method for producing highly pure Ibrutinib, enhancing its availability for medical use.

Career Highlights

Sriram Rampalli has worked with prominent companies in the pharmaceutical sector, including Shilpa Medicare Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and delivery.

Collaborations

Throughout his career, Rampalli has collaborated with talented professionals, including Lav Kumar Upalla and Prashant Purohit. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Sriram Rampalli's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in cancer treatment, showcasing the importance of innovation in healthcare.